Cargando…

How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study

BACKGROUND: Naloxone is a medication that can quickly reverse an opioid overdose. Syringe service programs (SSPs) are community-based prevention programs that provide a range of evidence-based interventions in the USA, including naloxone distribution. Attributes of SSPs make them ideal settings for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambdin, Barrot H., Wenger, Lynn, Bluthenthal, Ricky, Bartholomew, Tyler S., Tookes, Hansel E., LaKosky, Paul, O’Neill, Savannah, Kral, Alex H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972698/ https://www.ncbi.nlm.nih.gov/pubmed/36855181 http://dx.doi.org/10.1186/s12954-023-00755-4

Ejemplares similares

Overdose Education and Naloxone Distribution Within Syringe Service Programs — United States, 2019
por: Lambdin, Barrot H., et al.
Publicado: (2020)

Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency
por: Bartholomew, Tyler S., et al.
Publicado: (2023)

Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises
por: Wenger, Lynn D., et al.
Publicado: (2021)

Best practices for community-based overdose education and naloxone distribution programs: results from using the Delphi approach
por: Wenger, Lynn D., et al.
Publicado: (2022)

Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs
por: Patel, Sheila V., et al.
Publicado: (2023)

Systems analysis and improvement approach to improve naloxone distribution within syringe service programs: study protocol of a randomized controlled trial
por: Akiba, Christopher F., et al.
Publicado: (2023)

Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
por: Lambdin, Barrot H., et al.
Publicado: (2022)

Baseline differences in characteristics and risk behaviors among people who inject drugs by syringe exchange program modality: an analysis of the Miami IDEA syringe exchange
por: Iyengar, Siddharth, et al.
Publicado: (2019)

Syringe services program (SSP) operational changes during the COVID-19 global outbreak
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

Application of machine learning algorithms for localized syringe services program policy implementation – Florida, 2017
por: Bartholomew, Tyler S., et al.
Publicado: (2022)

The University of Miami Infectious Disease Elimination Act Syringe Services Program: A Blueprint for Student Advocacy, Education, and Innovation
por: Tookes, Hansel, et al.
Publicado: (2020)

Implementation and first-year operating costs of an academic medical center-based syringe services program
por: Bartholomew, Tyler S., et al.
Publicado: (2021)

Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

Correlates of injection‐related wounds and skin infections amongst persons who inject drugs and use a syringe service programme: A single center study
por: Cahn, Brian A., et al.
Publicado: (2021)

When is an abscess more than an abscess? Syringe services programs and the harm reduction safety-net: a case report
por: Castillo, Marcus, et al.
Publicado: (2020)

Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida
por: Jo, Young, et al.
Publicado: (2020)

Correction to: When is an abscess more than an abscess? Syringe services programs and the harm reduction safety-net: a case report
por: Castillo, Marcus, et al.
Publicado: (2020)

Access to Sterile Syringes through San Francisco Pharmacies and the Association with HIV Risk Behavior among Injection Drug Users
por: Riley, Elise D., et al.
Publicado: (2010)

The Impact of COVID-19 on Syringe Services Programs in the United States
por: Glick, Sara N., et al.
Publicado: (2020)

Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

1643. Infectious Sequelae of Injection Drug Use at a County Safety-Net Hospital Decline Following Establishment of a Syringe Service Program
por: Bornstein, Kasha J, et al.
Publicado: (2019)

Reduced Emergency Department Visits and Hospitalisation with Use of an Unsanctioned Safe Consumption Site for Injection Drug Use in the United States
por: Lambdin, Barrot H., et al.
Publicado: (2022)

Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016–2017
por: Serota, David P, et al.
Publicado: (2020)

Wounds and Skin and Soft Tissue Infections in People Who Inject Drugs and the Utility of Syringe Service Programs in Their Management
por: Sanchez, Daniela P., et al.
Publicado: (2021)

Hospital admissions among people who inject opioids following syringe services program implementation
por: Bornstein, K. J., et al.
Publicado: (2020)

Health risk associated with residential relocation among people who inject drugs in Los Angeles and San Francisco, CA: a cross sectional study
por: Chiang, Joey C., et al.
Publicado: (2022)

“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs
por: Bartholomew, Tyler S., et al.
Publicado: (2022)

Pharmacy Participation in Non-Prescription Syringe Sales in Los Angeles and San Francisco Counties, 2007
por: Cooper, Erin N., et al.
Publicado: (2010)

Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California
por: Lambdin, Barrot H., et al.
Publicado: (2017)

Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021
por: Des Jarlais, Don C., et al.
Publicado: (2022)

Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN(®) Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
por: Tippey, Kathryn G., et al.
Publicado: (2019)

Three Years after Legalization of Nonprescription Pharmacy Syringe Sales in California: Where Are We Now?
por: Garfein, Richard S., et al.
Publicado: (2010)

Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020()
por: Behrends, Czarina N., et al.
Publicado: (2022)

2667. Bridging the Gap: Sexually Transmitted Infections Testing, Treatment, and Prevention at a Miami Syringe Services Program for Women Who Inject Drugs
por: Herrera, Tara E, et al.
Publicado: (2023)

Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire
por: Bolivar, Derek, et al.
Publicado: (2023)

Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors
por: Enich, Michael, et al.
Publicado: (2023)

Responding to a surge in overdose deaths: perspectives from US syringe services programs
por: Frost, Madeline C., et al.
Publicado: (2022)

Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014–18
por: Jo, Young, et al.
Publicado: (2021)

Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine
por: Corcorran, Maria A., et al.
Publicado: (2023)

Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
por: Frost, Madeline C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k9fnapp9aj9tku7kepu8if22bn